Related Experiment Video
Updated: May 12, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Predictors of outcomes after PCI with incomplete revascularization: Impact of CTO and LAD vessel
Toshiki Kuno1,2,3, Giora Weisz4, Philippe Généreux5
1The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Insights
Incomplete revascularization (ICR) after percutaneous coronary intervention (PCI) involving the left anterior descending artery (LAD) showed similar outcomes to other coronary arteries. However, ICR in patients with chronic total occlusion (CTO) led to increased hospitalizations and myocardial infarctions.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Trials
Background:
- Incomplete revascularization (ICR) following percutaneous coronary intervention (PCI) is linked to adverse patient outcomes, including mortality and morbidity.
- Understanding the specific impact of ICR in different coronary arteries and in the presence of chronic total occlusions (CTO) is crucial for risk stratification and treatment optimization.
Purpose of the Study:
- To compare the clinical significance of ICR in the left anterior descending artery (LAD) versus the right coronary artery (RCA) or left circumflex artery (LCX).
- To evaluate whether ICR in patients with a non-recanalized chronic total occlusion (CTO) carries a worse prognosis than in patients without a CTO.
Main Methods:
- The study analyzed data from the RIVER-PCI trial, which enrolled 2651 patients with ICR after PCI, randomly assigned to ranolazine or placebo.
- Angiographic assessments were performed in 2501 patients (94.3%) by an independent core laboratory.
- The primary endpoint was a composite of ischemia-driven revascularization or hospitalization, with a median follow-up of 643 days.
Main Results:
- ICR involving the LAD occurred in 66.5% of patients, while ICR limited to the RCA or LCX occurred in 33.5%. The primary endpoint rates were similar between these groups (26.9% vs. 26.5%).
- A non-recanalized CTO was present in 34.1% of patients with ICR. The primary endpoint occurred slightly more often in patients with CTO (28.6% vs. 25.9%), though not statistically significant.
- Patients with CTO experienced significantly higher rates of ischemia-driven hospitalization without revascularization (aHR: 1.27), heart failure hospitalization (aHR: 2.69), and myocardial infarction (aHR: 1.46) compared to those without CTO.
Conclusions:
- The 2-year prognosis for patients with incomplete revascularization after PCI is similar regardless of whether the left anterior descending artery is involved.
- Incomplete revascularization in patients with a co-existing chronic total occlusion is associated with a higher incidence of hospitalizations for ischemia and myocardial infarctions.
Background:
Incomplete revascularization (ICR) after percutaneous coronary intervention (PCI) is associated with mortality and morbidity.
Aim:
We sought to investigate whether ICR in the left anterior descending artery (LAD) is worse than ICR of the right coronary artery (RCA) or left circumflex artery (LCX); and whether ICR in patients with a chronic total occlusion (CTO) is worse than in those without.
Methods:
In the RIVER-PCI trial, 2651 patients with ICR after PCI were randomly assigned to ranolazine or placebo. Angiograms were assessed at an independent core laboratory in 2501 patients (94.3%). The primary endpoint was the composite of ischemia-driven revascularization or hospitalization.
Results:
A total of 1664 patients (66.5%) had ICR involving the LAD, whereas 837 (33.5%) had ICR limited to the RCA or LCX. At median follow-up of 643 days, the primary endpoint occurred in 26.9% versus 26.5% of patients (adjusted HR [aHR]: 1.03, 95% confidence interval [CI]: 0.88-1.21). A nonrecanalized CTO was present in 854 patients (34.1%) with ICR after PCI. The primary endpoint occurred in 28.6% versus 25.9% of ICR patients with versus without a CTO (aHR: 1.10, 95% CI: 0.94-1.29). However, patients with a CTO had higher rates of ischemia-driven hospitalization without revascularization (aHR: 1.27, 95% CI: 1.04-1.56), heart failure hospitalization (aHR: 2.69, 95% CI: 1.61-4.59) and myocardial infarction (aHR: 1.46, 95% CI: 1.11-1.92) compared with those without.
Conclusions:
The 2-year prognosis was similar in post-PCI patients with ICR whether the LAD was versus was not involved. ICR patients with a CTO had more frequent hospitalizations for ischemia and myocardial infarctions compared with those without.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies